关注
Som Mukherjee
Som Mukherjee
Associate Professor, McMaster University
在 hhsc.ca 的电子邮件经过验证
标题
引用次数
引用次数
年份
Abiraterone in metastatic prostate cancer without previous chemotherapy
CJ Ryan, MR Smith, JS De Bono, A Molina, CJ Logothetis, P De Souza, ...
New England Journal of Medicine 368 (2), 138-148, 2013
32102013
Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma …
T Powles, MS van der Heijden, D Castellano, MD Galsky, Y Loriot, ...
The Lancet Oncology 21 (12), 1574-1588, 2020
3982020
Adjuvant therapy for completely resected stage II colon cancer
A Figueredo, ME Coombes, S Mukherjee
Cochrane Database of Systematic Reviews, 2008
3782008
External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative …
TJ Whelan, JA Julian, TS Berrang, DH Kim, I Germain, AM Nichol, M Akra, ...
The Lancet 394 (10215), 2165-2172, 2019
3462019
Breast cancer chemotherapy induces the release of cell‐free DNA, a novel procoagulant stimulus
LL Swystun, S Mukherjee, PC Liaw
Journal of Thrombosis and Haemostasis 9 (11), 2313-2321, 2011
1992011
Randomized trial of a telephone-based weight loss intervention in postmenopausal women with breast cancer receiving letrozole: the LISA trial
PJ Goodwin, RJ Segal, M Vallis, JA Ligibel, GR Pond, A Robidoux, ...
J Clin Oncol 32 (21), 2231-2239, 2014
1872014
Nanoparticle albumin-bound paclitaxel for second-line treatment of metastatic urothelial carcinoma: a single group, multicentre, phase 2 study
YJ Ko, CM Canil, SD Mukherjee, E Winquist, C Elser, A Eisen, ...
The lancet oncology 14 (8), 769-776, 2013
1602013
Effect of metformin vs placebo on weight and metabolic factors in NCIC CTG MA. 32
PJ Goodwin, WR Parulekar, KA Gelmon, LE Shepherd, JA Ligibel, ...
Journal of the National Cancer Institute 107 (3), djv006, 2015
1462015
Randomized phase II trial of Custirsen (OGX-011) in combination with docetaxel or mitoxantrone as second-line therapy in patients with metastatic castrate-resistant prostate …
F Saad, S Hotte, S North, B Eigl, K Chi, P Czaykowski, L Wood, M Pollak, ...
Clinical Cancer Research 17 (17), 5765-5773, 2011
1422011
Cardiac complications associated with checkpoint inhibition: a systematic review of the literature in an important emerging area
H Mir, M Alhussein, S Alrashidi, H Alzayer, A Alshatti, N Valettas, ...
Canadian Journal of Cardiology 34 (8), 1059-1068, 2018
1292018
Effect of metformin vs placebo on invasive disease–free survival in patients with breast cancer: the MA. 32 randomized clinical trial
PJ Goodwin, BE Chen, KA Gelmon, TJ Whelan, M Ennis, J Lemieux, ...
Jama 327 (20), 1963-1973, 2022
1192022
A phase I dose-escalation study of apatorsen (OGX-427), an antisense inhibitor targeting heat shock protein 27 (Hsp27), in patients with castration-resistant prostate cancer …
KN Chi, EY Yu, C Jacobs, J Bazov, C Kollmannsberger, CS Higano, ...
Annals of Oncology 27 (6), 1116-1122, 2016
1052016
A phase II trial of sorafenib in first-line metastatic urothelial cancer: a study of the PMH Phase II Consortium
SS Sridhar, E Winquist, A Eisen, SJ Hotte, E McWhirter, IF Tannock, ...
Investigational new drugs 29, 1045-1049, 2011
1002011
Custirsen in combination with docetaxel and prednisone for patients with metastatic castration-resistant prostate cancer (SYNERGY trial): a phase 3, multicentre, open-label …
KN Chi, CS Higano, B Blumenstein, JM Ferrero, J Reeves, S Feyerabend, ...
The lancet oncology 18 (4), 473-485, 2017
882017
Is red meat intake a risk factor for breast cancer among premenopausal women?
VH Taylor, M Misra, SD Mukherjee
Breast cancer research and treatment 117 (1), 1-8, 2009
862009
Cardiovascular risk in men with prostate cancer: insights from the RADICAL PC study
DP Leong, V Fradet, B Shayegan, E Duceppe, R Siemens, T Niazi, L Klotz, ...
The Journal of urology 203 (6), 1109-1116, 2020
852020
Safety of continuing trastuzumab despite mild cardiotoxicity: a phase I trial
DP Leong, T Cosman, MM Alhussein, N Kumar Tyagi, S Karampatos, ...
Cardio Oncology 1 (1), 1-10, 2019
762019
Tn-MUC1 DC vaccination of rhesus macaques and a phase I/II trial in patients with nonmetastatic castrate-resistant prostate cancer
E Scheid, P Major, A Bergeron, OJ Finn, RD Salter, R Eady, ...
Cancer immunology research 4 (10), 881-892, 2016
682016
Statin therapy in the treatment of active cancer: A systematic review and meta-analysis of randomized controlled trials
MAM Farooqi, N Malhotra, SD Mukherjee, S Sanger, SK Dhesy-Thind, ...
PloS one 13 (12), e0209486, 2018
652018
Improvements in Radiographic Progression-Free Survival Stratified by ERG Gene Status in Metastatic Castration-Resistant Prostate Cancer Patients Treated with …
G Attard, JS De Bono, CJ Logothetis, K Fizazi, SD Mukherjee, AM Joshua, ...
Clinical cancer research 21 (7), 1621-1627, 2015
602015
系统目前无法执行此操作,请稍后再试。
文章 1–20